Showing results (531-540 of 884) with videos related to

Sort By:
Pageof 89
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|March 5, 2016
The prognostic value of non-perfusion variables obtained during vasodilator stress myocardial perfusion imagingNavkaranbir S Bajaj, Siddharth Singh, Ayman Farag, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 9, 2022
Comparative Risk of Serious Infections With Biologic Agents and Oral Small Molecules in Inflammatory Bowel Diseases: A Systematic Review and Meta-AnalysisVirginia Solitano, Antonio Facciorusso, Tine Jess, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 20, 2020
Systematic Review of Prevalence, Risk Factors, and Risk for Metachronous Advanced Neoplasia in Patients With Young-Onset Colorectal AdenomaNgozi Enwerem, Moo Y Cho, Joshua Demb, et al.
JACC. Case Reports|May 30, 2025
Post SARS-CoV-2 Myocarditis: Giant Cell or MIS-A? A Misdiagnosis Leading to a Heart TransplantationSiyi Shangguan, Pooja S Desai, Siddharth Singh, et al.
The American Journal of Gastroenterology|November 9, 2021
Digital Health Technologies for Remote Monitoring and Management of Inflammatory Bowel Disease: A Systematic ReviewNghia H Nguyen, Ivonne Martinez, Ashish Atreja, et al.
Alimentary Pharmacology & Therapeutics|August 26, 2021
Systematic review with network meta-analysis: comparative efficacy of pharmacologic therapies for fibrosis improvement and resolution of NASHAbdul M Majzoub, Tarek Nayfeh, Abbey Barnard, et al.
The American Journal of the Medical Sciences|February 2, 2025
A decade in disguise masquerading as recurrent pneumoniaDr Aneri Parekh, Dr Pritinanda Mishra, Dr Mahismita Patro, et al.
Surgical Endoscopy|November 22, 2023
The hospital frailty risk score as a predictor of readmission after ERCPKhanh Hoang Nicholas Le, Alexander S Qian, Mimi Nguyen, et al.
The Lancet. Gastroenterology & Hepatology|October 24, 2021
Comparative efficacy and safety of biologic therapies for moderate-to-severe Crohn's disease: a systematic review and network meta-analysisSiddharth Singh, M Hassan Murad, Mathurin Fumery, et al.
Pageof 89